Asset
APATORSEN SODIUM
Achieve Life Sciences Inc. Common Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01454089 | phase2 | completed | 2011-10-01 | 2014-11-01 | Achieve Life Sciences | A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer |
| NCT00487786 | phase1 | completed | 2007-06-01 | 2011-06-01 | Achieve Life Sciences | Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer |
FDA applications (0)
This company has no applications containing this asset.